Publications

Mayeta Clark 2015

Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria

June 29, 2021

Background: Plasmodium falciparum causes placental malaria, which results in adverse outcomes for mother and child. P. falciparum-infected erythrocytes that express the parasite protein…

Read More

Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria

June 28, 2021

Background: The efficacy of artemisinin-based combination therapies (ACTs), the first-line treatments for uncomplicated falciparum malaria, has been declining in malaria-endemic countries…

Read More

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study

June 1, 2021

Background: In 2017, an estimated 14 million cases of Plasmodium vivax malaria were reported from Asia, Central and South America, and…

Read More

Community-based molecular and serological surveillance of subclinical malaria in Myanmar

May 28, 2021

Background In the Greater Mekong Subregion (GMS), current malaria surveillance strategies rely on a network of village health volunteers (VHVs)…

Read More

Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh

April 23, 2021

Background Glucose-6-phosphate dehydrogenase (G6PD) activity is dependent upon G6PD genotype and age of the red blood cell (RBC) population, with…

Read More

The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools

April 23, 2021

Sarah Auburn and co-authors discuss the unique biology and epidemiology of P. vivax and current evidence on conventional and new…

Read More

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study

April 23, 2021

Background Despite recent intensification of control measures, Plasmodium vivax poses a major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause…

Read More

Optimizing Myanmar’s community-delivered malaria volunteer model: a qualitative study of stakeholders’ perspectives

February 8, 2021

Background In parallel with the change of malaria policy from control to elimination and declines in the malaria burden in…

Read More

The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network

November 19, 2020

Background There is a high risk of Plasmodium vivax parasitaemia following treatment of falciparum malaria. Our study aimed to quantify this risk…

Read More

Monitoring Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea

September 28, 2020

Monitoring the genetic structure of pathogen populations may be an economical and sensitive approach to quantify the impact of control…

Read More

1 2 3 14